155 related articles for article (PubMed ID: 38246042)
21. Do endometrial cancer patients benefit from metformin intake?
Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
[TBL] [Abstract][Full Text] [Related]
22. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
Zhang ZJ; Li S
Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
[TBL] [Abstract][Full Text] [Related]
24. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
[TBL] [Abstract][Full Text] [Related]
25. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.
Liao C; Zhang D; Mungo C; Tompkins DA; Zeidan AM
Gynecol Oncol; 2014 Oct; 135(1):163-71. PubMed ID: 25072931
[TBL] [Abstract][Full Text] [Related]
26. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
Feng JL; Qin X
Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
[TBL] [Abstract][Full Text] [Related]
27. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.
Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P
Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653
[TBL] [Abstract][Full Text] [Related]
28. Effects of metformin on endometrial cancer: Systematic review and meta-analysis.
Meireles CG; Pereira SA; Valadares LP; Rêgo DF; Simeoni LA; Guerra ENS; Lofrano-Porto A
Gynecol Oncol; 2017 Oct; 147(1):167-180. PubMed ID: 28760367
[TBL] [Abstract][Full Text] [Related]
29. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis.
Han Y; Xie H; Liu Y; Gao P; Yang X; Shen Z
Cardiovasc Diabetol; 2019 Jul; 18(1):96. PubMed ID: 31362743
[TBL] [Abstract][Full Text] [Related]
30. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
31. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
[TBL] [Abstract][Full Text] [Related]
32. Metformin monotherapy for adults with type 2 diabetes mellitus.
Gnesin F; Thuesen ACB; Kähler LKA; Madsbad S; Hemmingsen B
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012906. PubMed ID: 32501595
[TBL] [Abstract][Full Text] [Related]
33. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
35. Effect of metformin use on the risk and prognosis of ovarian cancer: an updated systematic review and meta-analysis.
Lu MZ; Li DY; Wang XF
Panminerva Med; 2023 Sep; 65(3):351-361. PubMed ID: 31290300
[TBL] [Abstract][Full Text] [Related]
36. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
37. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
[TBL] [Abstract][Full Text] [Related]
38. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
39. Metformin use and endometrial cancer survival.
Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
[TBL] [Abstract][Full Text] [Related]
40. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
